Reply

Thank you to Drs Blair and Shapiro for their letter. Their comment about equipoise in the evaluation of controversies in retinopathy of prematurity (ROP) management could not be more germane. By citing an US Food and Drug Administration warning, the authors note possible danger in the use of general anesthesia in young children, a point in favor of intravitreal bevacizumab (IVB). This warning should be elaborated for the interested reader.1 The US Food and Drug Administration recommends against prolonged anesthesia (>3 hours) in children

Source: Ophthalmology - September 19, 2017 Category: Opthalmology Authors: William V. Good Tags: Correspondence Source Type: research